HPV16/18 antibodies 16-years after single dose of bivalent HPV vaccination: Costa Rica HPV vaccine trial
HPV-16/18 seropositivity remained exceedingly high 16 years after vaccination. Over 5 years, small declines in antibodies were observed. Women should have protection for at least 20 years and likely much longer at the observed rate of decline.
Authors
- Paula González (ORCID: https://orcid.org/0000-0003-0154-0087)
- Mark E. Sherman (ORCID: https://orcid.org/0000-0002-9222-8808)
- Mary Sidawy
- Byron Romero
- Danping Liu (ORCID: https://orcid.org/0000-0001-5483-6303)
- Ana Cecilia Rodríguez (ORCID: https://orcid.org/0000-0001-9866-2106)
- Mónica S. Sierra
- Troy J. Kemp
- Wim Quint (ORCID: https://orcid.org/0000-0001-8616-9410)
- Rolando Herrero (ORCID: https://orcid.org/0000-0001-5448-3456)
- Sholom Wacholder
- Linda Struijk (ORCID: https://orcid.org/0000-0001-9508-6924)
- Teresa M. Darragh (ORCID: https://orcid.org/0000-0002-4382-9949)
- Mark H. Stoler (ORCID: https://orcid.org/0000-0002-2784-1008)
- Ligia A. Pinto
- Lígia A. Pinto (ORCID: https://orcid.org/0000-0002-3130-9882)
- Romain Fantin (ORCID: https://orcid.org/0000-0003-2906-3438)
- Troy J. Kemp (ORCID: https://orcid.org/0000-0002-1197-7525)
- John Schussler (ORCID: https://orcid.org/0000-0002-8793-0766)
- Silvia E Jiménez
- Mitchell H. Gail (ORCID: https://orcid.org/0000-0002-3919-3263)
- Rebeca Ocampo (ORCID: https://orcid.org/0000-0002-8069-5142)
- John T. Schiller (ORCID: https://orcid.org/0000-0001-7308-950X)
- Joel M. Palefsky (ORCID: https://orcid.org/0000-0002-5097-3818)
- Douglas R. Lowy (ORCID: https://orcid.org/0000-0003-0635-219X)
- Mark Schiffman (ORCID: https://orcid.org/0000-0001-9000-9671)
- Carolina Porras (ORCID: https://orcid.org/0000-0002-4592-3883)
- Leen‐Jan van Doorn
- Allan Hildesheim
- Bernal Cortés
Institutions
- Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud (CR)
- Information Management Services (US)
- Frederick National Laboratory for Cancer Research (US)
- National Cancer Institute (US)
- Center for Cancer Research (US)
- Division of Cancer Epidemiology and Genetics
Publication Details
- Journal
- JNCI Monographs
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1093/jncimonographs/lgae032
- Citations
- 26
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 10.05
Funders
- Bill and Melinda Gates Foundation
- GlaxoSmithKline
- National Institutes of Health
- National Cancer Institute
- Office of Research on Women's Health